![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Renal and Bone Safety of Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate
|
|
|
Combined Safety Results of Studies GS-US-292-0104 and GS-US-292-0111
Reported by Jules Levin
CROI 2015 Feb 23-26, Seattle, WA
Paul Sax1, Michael Saag2, Michael Yin3, Frank Post4, Shinichi Oka5, Ellen Koenig6, Benoit Trottier7, Jaime Andrade-Villanueva8,
Huyen Cao9, Marshall Fordyce9
1Brigham and Women's Hospital and Harvard Medical School, Boston, MA; 2University of Alabama Birmingham, Birmingham, AL; 3College of Physicians and Surgeons, Columbia University, New York, NY; 4King's College, London, UK; 5National Center for Global Health and Medicine, Tokyo, Japan; 6Dominican Institute for Virologic Studies, Santo Domingo, Dominican Republic; 7Clinique Medicale L'Actuale in Montreal, Montreal, Canada; 8Unidad de VIH del Hospital Civil de Guadalajara, Guadalajara, Mexico; 9Gilead Sciences, Foster City, CA
![CROI1.gif](../images/022715/022715-3/CROI1.gif)
![CROI2.gif](../images/022715/022715-3/CROI2.gif)
![CROI3.gif](../images/022715/022715-3/CROI3.gif)
![CROI4.gif](../images/022715/022715-3/CROI4.gif)
![CROI5.gif](../images/022715/022715-3/CROI5.gif)
![CROI6.gif](../images/022715/022715-3/CROI6.gif)
![CROI7.gif](../images/022715/022715-3/CROI7.gif)
![CROI8.gif](../images/022715/022715-3/CROI8.gif)
![CROI9.gif](../images/022715/022715-3/CROI9.gif)
![CROI10.gif](../images/022715/022715-3/CROI10.gif)
![CROI11.gif](../images/022715/022715-3/CROI11.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|